Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 009682/0854 | |
| Pages: | 5 |
| | Recorded: | 12/29/1998 | | |
| Conveyance: | CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/23/2002
|
Application #:
|
09115387
|
Filing Dt:
|
07/14/1998
|
|
Publication #:
|
|
Pub Dt:
|
06/27/2002
| | | | |
|
Title:
|
UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY AGENTS THAT DISRUPT ACTIN CYTOSKELETAL ORGANIZATION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2001
|
Application #:
|
09132849
|
Filing Dt:
|
08/11/1998
|
|
Title:
|
UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY RHO GTPASE FUNCTION INHIBITORS
|
|
|
Assignee
|
|
|
|
|
| EXTRAMURAL INVENTIONS OFFICE, THE |
| 6701 ROCKLEDGE DRIVE, ROOM 3188, MSC 7750 |
| BETHESDA, MARYLAND 20892 |
|
|
Correspondence name and address
|
| |
NATIONAL INSTITUTES OF HEALTH, THE
|
| |
BELEN AWETAHEGNE
|
| |
EXTRAMURAL INVENTIONS OFFICE, THE
|
| |
6701 ROCKLEDGE DR., RM 3188, MSC 7750
|
| |
BETHESDA, MARYLAND 20892-7750
|
Search Results as of:
05/06/2024 02:08 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
